TONIX PHARMACEUTICALS HLDG C

Historical 13F Holders

Symbol
TNXP
CUSIP
890260839
All holders as of
Q2 2026
Type
Equity
Class
COM NEW
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 890260839 since 12/18/2024, largest first.

Filer % of Class Filed
Point72 Asset Management, L.P. 13G/A
6.9% 5/15/2026
Event 3/31/2026
BlackRock, Inc. 13G/A 6.7% 1/21/2026
Event 12/31/2025
Millennium Management LLC 13G
5.6% 6/15/2026
Event 6/9/2026
AQR Capital Management, LLC 13G
5.5% 8/13/2026
Event 6/30/2026
Under 5%, checked the "5 percent or less" box, or amended by a later filing (2)
Sirenia Capital Management LP 13G/A
4.9% 8/14/2026
Event 6/30/2026
Vanguard Group Inc 13G/A 0% 3/27/2026
Event 3/13/2026

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q3 3 986 $9.60 k
2026 Q2 109 9.36 M $120 M
2026 Q1 88 4.87 M $67.0 M
2025 Q4 76 3.74 M $58.5 M
2025 Q3 65 2.36 M $57.1 M
2025 Q2 49 1.39 M $50.1 M
2025 Q1 27 477 k $8.53 M
2024 Q4 2 5.38 k $1.77 k